Patents by Inventor Wolfgang HIDDEMANN

Wolfgang HIDDEMANN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBCUTANEOUSLY ADMINISTERED BISPECIFIC ANTIBODIES FOR USE IN THE TREATMENT OF CANCER
    Publication number: 20170224818
    Abstract: The present invention relates to the use of T cell redirecting, bispecific, in particular trifunctional, antibodies for the treatment of a cancer disease, wherein said antibody is administered via the subcutaneous route. Thereby, the release of proinflammatory cytokines is reduced and, simultaneously, the release of inhibitory cytokines is substantially suppressed. That treatment by bispecific, in particular trifunctional, antibodies may be combined in a combination therapy with other anti-cancer drugs.
    Type: Application
    Filed: August 10, 2015
    Publication date: August 10, 2017
    Inventors: Horst LINDHOFER, Raymund BUHMANN, Martin DREYLING, Wolfgang HIDDEMANN